Celgene in Novartis deal

Novartis (SWX:NOVN) acquired an exclusive global license, excluding Canada, to CELG's d-methylphenidate, a chirally pure form of Ritalin, to treat attention deficit disorder and attention deficit hyperactivity

Read the full 279 word article

How to gain access

Continue reading with a
two-week free trial.